SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-22-079174
Filing Date
2022-12-12
Accepted
2022-12-12 17:25:40
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-1 ea170014-f1a1_biondvax.htm F-1/A 1870288
2 OPINION OF GROSS & CO ea170014ex5-1_biondvax.htm EX-5.1 8413
3 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M ea170014ex23-1_biondvax.htm EX-23.1 2578
4 CALCULATION OF FILING FEE TABLES ea170014ex107-1_biondvax.htm EX-FILING FEES 45733
5 GRAPHIC image_001.jpg GRAPHIC 21995
6 GRAPHIC fin_001.jpg GRAPHIC 25395
  Complete submission text file 0001213900-22-079174.txt   1993622
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-267648 | Film No.: 221457957
SIC: 2836 Biological Products, (No Diagnostic Substances)